Direct effects of canagliflozin on human myocardial redox signalling: a novel role for SGLT1 inhibition
Auteurs principaux: | Kondo, H, Akoumianakis, I, Akawi, N, Kotanidis, C, Antonopoulos, A, Carena, M, Badi, I, Oikonomou, E, Reus, E, Krasopoulos, G, Chuaiphichai, S, Shirodaria, C, Channon, K, Casadei, B, Antoniades, C |
---|---|
Format: | Conference item |
Langue: | English |
Publié: |
Oxford University Press
2020
|
Documents similaires
-
Novel direct effects of SGLT2 inhibitor, Canagliflozin, on myocardial redox state in humans
par: Kondo, H, et autres
Publié: (2019) -
Effects of canagliflozin on human myocardial redox signalling: clinical implications
par: Kondo, H, et autres
Publié: (2021) -
Human epicardial adipose tissue-secreted miR-92a-3p regulates myocardial redox state via paracrine signalling: implications for cardiovascular clinical outcomes
par: Badi, I, et autres
Publié: (2023) -
Role of human epicardial adipose tissue–derived miR-92a-3p in myocardial redox state
par: Carena, MC, et autres
Publié: (2023) -
Myocardial redox state predicts 3-year mortality in patients undergoing cardiac surgery: the ox-HVF study
par: Kotanidis, C, et autres
Publié: (2019)